概括
热针疗法为癌症治疗诱导的血小板缩 (CTIT) 提供了一个有希望的补充治疗,当传统方法不足时. 这种方法帮助两名耐火性CTIT患者实现了显著的血小板数恢复.
科学领域:
- 在瘤学瘤学.
- 综合医学是一个整体的医学.
- 血液学 血液学 血液学
背景情况:
- 癌症治疗诱导的血小板缺血 (CTIT) 是抗瘤疗法的常见并发症.
- 在患有严重骨髓抑制或对血栓形成药物的低反应的患者中,CTIT的标准治疗可能是无效的.
研究的目的:
- 评估热针治疗作为癌症治疗诱导的血小板缩 (CTIT) 耐常药治疗的患者的辅助治疗的疗效.
主要方法:
- 介绍了两项CTIT患者的病例研究,这些患者对标准治疗没有反应.
- 热针治疗是作为常规护理的补充治疗.
- 在干预之前和之后,对患者的血小板计数进行了监测.
主要成果:
- 案例1:一个对常规治疗耐药的CTIT患者在经过两周热针后,血小板数从20×10^9/L持续增加到122×10^9/L.
- 案例2:一个患有持续性血小板缺血的患者经历了热针和持续放射治疗后的血小板计数从39×10^9/L回升到187×10^9/L.
结论:
- 热针疗法可以作为耐药癌症治疗诱导的血小板缩 (CTIT) 的有益补充治疗.
- 需要进一步的研究来确定热针在管理CTIT中的作用.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
433
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
433
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:49Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K